Results

Total Results: 68 records

Showing results for "buprenorphine".

61. 2023 National Healthcare Quality and Disparities Report (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-nhqdr-es.pdf
    January 01, 2023 - systems to prescribe medication for opioid use disorder (MOUD, which includes treatment with methadone, buprenorphine

62. 2023 National Healthcare Quality and Disparities Report (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-nhqdr-es-rev.pdf
    January 01, 2023 - systems to prescribe medication for opioid use disorder (MOUD, which includes treatment with methadone, buprenorphine

63. Weighted Frequency tables: PUF Medicare Pharmacy (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Medicare-Pharmacy.pdf
    April 01, 2021 - BUPIVACAINE-EPINEPHRINE 140553.4 0.01 2.4979E8 17.77 BUPIVACAINE-FENTANYL 114.57 0.00 2.4979E8 17.77 BUPRENORPHINE … 375779.9 0.03 2.5017E8 17.79 BUPRENORPHINE-NALOXONE 373355.5 0.03 2.5054E8 17.82 BUPROPION 6157900

64. SyH-DR PUF Summary Statistics-Medicaid Pharmacy Weighted (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Medicaid-Pharmacy.pdf
    April 01, 2021 - BUPIVACAINE-EPINEPHRINE 4775.89 0.00 1.2767E8 20.91 BUPIVACAINE-FENTANYL 78.75 0.00 1.2767E8 20.91 BUPRENORPHINE … 145937.1 0.02 1.2782E8 20.93 BUPRENORPHINE-NALOXONE 515267 0.08 1.2834E8 21.02 BUPROPION 3549089

65. Six Building Blocks How-To-Implement Toolkit: Prepare and Launch Guide (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/settings/ambulatory/6bb-toolkit-prepare.pdf
    February 18, 2021 - database • Patient agreements • Patient education • Tapering of opioids • Use of naloxone • Use of buprenorphine

66. Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hac-cost-report2017.pdf
    November 01, 2017 - mh]) OR (“analgesics, opioid”[mh] OR opioid*[tiab] OR “Alfentanil”[mh] OR “Alphaprodine”[mh] OR “Buprenorphine … ”[mh] OR “Buprenorphine, Naloxone Drug Combination”[mh] OR “Butorphanol”[mh] OR “Codeine”[mh] OR “Dextromoramide

67. Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions (pdf file)
    www.ahrq.gov/sites/default/files/publications2/files/hac-cost-report2017.pdf
    November 01, 2017 - mh]) OR (“analgesics, opioid”[mh] OR opioid*[tiab] OR “Alfentanil”[mh] OR “Alphaprodine”[mh] OR “Buprenorphine … ”[mh] OR “Buprenorphine, Naloxone Drug Combination”[mh] OR “Butorphanol”[mh] OR “Codeine”[mh] OR “Dextromoramide

68. Using Rapid-Cycle Research to Reach Goals: Awareness, Assessment, Adaptation, Acceleration (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/resources/final-rapid-cycle-research-guidance.pdf
    June 01, 2015 - Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment … Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment